Cargando…

Characterization of human adenovirus 35 and derivation of complex vectors

BACKGROUND: Replication-deficient recombinant adenoviral vectors based on human serotype 35 (Ad35) are desirable due to the relatively low prevalence of neutralizing antibodies in the human population. The structure of the viral genome and life cycle of Ad35 differs from the better characterized Ad5...

Descripción completa

Detalles Bibliográficos
Autores principales: McVey, Duncan, Zuber, Mohammed, EttyReddy, Damodar, Reiter, Christopher D, Brough, Douglas E, Nabel, Gary J, King, C Richter, Gall, Jason G D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984591/
https://www.ncbi.nlm.nih.gov/pubmed/20959004
http://dx.doi.org/10.1186/1743-422X-7-276
_version_ 1782192120828788736
author McVey, Duncan
Zuber, Mohammed
EttyReddy, Damodar
Reiter, Christopher D
Brough, Douglas E
Nabel, Gary J
King, C Richter
Gall, Jason G D
author_facet McVey, Duncan
Zuber, Mohammed
EttyReddy, Damodar
Reiter, Christopher D
Brough, Douglas E
Nabel, Gary J
King, C Richter
Gall, Jason G D
author_sort McVey, Duncan
collection PubMed
description BACKGROUND: Replication-deficient recombinant adenoviral vectors based on human serotype 35 (Ad35) are desirable due to the relatively low prevalence of neutralizing antibodies in the human population. The structure of the viral genome and life cycle of Ad35 differs from the better characterized Ad5 and these differences require differences in the strategies for the generation of vectors for gene delivery. RESULTS: Sequences essential for E1 and E4 function were identified and removed and the effects of the deletions on viral gene transcription were determined. In addition, the non-essential E3 region was deleted from rAd35 vectors and a sequence was found that did not have an effect on viability but reduced viral fitness. The packaging capacity of rAd35 was dependent on pIX and vectors were generated with stable genome sizes of up to 104% of the wild type genome size. These data were used to make an E1-, E3-, E4-deleted rAd35 vector. This rAd35 vector with multiple gene deletions has the advantages of multiple blocks to viral replication (i.e., E1 and E4 deletions) and a transgene packaging capacity of 7.6 Kb, comparable to rAd5 vectors. CONCLUSIONS: The results reported here allow the generation of larger capacity rAd35 vectors and will guide the derivation of adenovirus vectors from other serotypes.
format Text
id pubmed-2984591
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29845912010-11-19 Characterization of human adenovirus 35 and derivation of complex vectors McVey, Duncan Zuber, Mohammed EttyReddy, Damodar Reiter, Christopher D Brough, Douglas E Nabel, Gary J King, C Richter Gall, Jason G D Virol J Research BACKGROUND: Replication-deficient recombinant adenoviral vectors based on human serotype 35 (Ad35) are desirable due to the relatively low prevalence of neutralizing antibodies in the human population. The structure of the viral genome and life cycle of Ad35 differs from the better characterized Ad5 and these differences require differences in the strategies for the generation of vectors for gene delivery. RESULTS: Sequences essential for E1 and E4 function were identified and removed and the effects of the deletions on viral gene transcription were determined. In addition, the non-essential E3 region was deleted from rAd35 vectors and a sequence was found that did not have an effect on viability but reduced viral fitness. The packaging capacity of rAd35 was dependent on pIX and vectors were generated with stable genome sizes of up to 104% of the wild type genome size. These data were used to make an E1-, E3-, E4-deleted rAd35 vector. This rAd35 vector with multiple gene deletions has the advantages of multiple blocks to viral replication (i.e., E1 and E4 deletions) and a transgene packaging capacity of 7.6 Kb, comparable to rAd5 vectors. CONCLUSIONS: The results reported here allow the generation of larger capacity rAd35 vectors and will guide the derivation of adenovirus vectors from other serotypes. BioMed Central 2010-10-19 /pmc/articles/PMC2984591/ /pubmed/20959004 http://dx.doi.org/10.1186/1743-422X-7-276 Text en Copyright © 2010 McVey et al; licensee BioMed Central Ltd. https://creativecommons.org/licenses/by/2.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0 (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
McVey, Duncan
Zuber, Mohammed
EttyReddy, Damodar
Reiter, Christopher D
Brough, Douglas E
Nabel, Gary J
King, C Richter
Gall, Jason G D
Characterization of human adenovirus 35 and derivation of complex vectors
title Characterization of human adenovirus 35 and derivation of complex vectors
title_full Characterization of human adenovirus 35 and derivation of complex vectors
title_fullStr Characterization of human adenovirus 35 and derivation of complex vectors
title_full_unstemmed Characterization of human adenovirus 35 and derivation of complex vectors
title_short Characterization of human adenovirus 35 and derivation of complex vectors
title_sort characterization of human adenovirus 35 and derivation of complex vectors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984591/
https://www.ncbi.nlm.nih.gov/pubmed/20959004
http://dx.doi.org/10.1186/1743-422X-7-276
work_keys_str_mv AT mcveyduncan characterizationofhumanadenovirus35andderivationofcomplexvectors
AT zubermohammed characterizationofhumanadenovirus35andderivationofcomplexvectors
AT ettyreddydamodar characterizationofhumanadenovirus35andderivationofcomplexvectors
AT reiterchristopherd characterizationofhumanadenovirus35andderivationofcomplexvectors
AT broughdouglase characterizationofhumanadenovirus35andderivationofcomplexvectors
AT nabelgaryj characterizationofhumanadenovirus35andderivationofcomplexvectors
AT kingcrichter characterizationofhumanadenovirus35andderivationofcomplexvectors
AT galljasongd characterizationofhumanadenovirus35andderivationofcomplexvectors